Status:
COMPLETED
Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain
Lead Sponsor:
ZARS Pharma Inc.
Conditions:
Pain
Eligibility:
All Genders
40-75 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the effectiveness of the Matrix Fentanyl Patch ZR-02-01 in providing pain relief.
Detailed Description
This study will evaluate the analgesic efficacy of the matrix fentanyl patch. The study will be conducted in non-opioid tolerant patients with moderate to severe osteoarthritis (OA) pain. This patient...
Eligibility Criteria
Inclusion
- Adults between the ages of 40 and 75 years of age suffering from moderate to severe chronic pain caused by osteoarthritis.
Exclusion
- Patient is already taking chronic opioids or has a history of substance abuse or has a substance abuse disorder.
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT00108771
Start Date
April 1 2004
End Date
September 1 2006
Last Update
June 5 2012
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Arizona Reserach Center
Phoenix, Arizona, United States, 85023
2
Redpoint Research
Phoenix, Arizona, United States, 85029
3
Sharp Rees-Stealy Medical Group
San Diego, California, United States, 92101
4
San Diego Arthritis Medical Clinic
San Diego, California, United States, 92108